Akoya Biosciences Inc (AKYA) — Cash Flow-to-Debt Ratio
Akoya Biosciences Inc (AKYA) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2025, meaning its operating cash flow of $-7.21 Million could theoretically repay 0% of its total liabilities ($118.54 Million) in one year. See Akoya Biosciences Inc (AKYA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Akoya Biosciences Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Akoya Biosciences Inc across 6 annual periods. Also explore net asset growth rate of Akoya Biosciences Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Akoya Biosciences Inc (2019–2024)
Year-by-year debt coverage analysis for Akoya Biosciences Inc. For market capitalisation and broader financial context, see Akoya Biosciences Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.38x | $-44.10 Million | $117.41 Million | ▲ +6.6% |
| 2023 | -0.40x | $-50.90 Million | $126.60 Million | ▲ +11.7% |
| 2022 | -0.46x | $-53.50 Million | $117.45 Million | ▲ +12.2% |
| 2021 | -0.52x | $-36.07 Million | $69.56 Million | ▼ -347.8% |
| 2020 | -0.12x | $-6.84 Million | $59.09 Million | ▼ -0.5% |
| 2019 | -0.12x | $-13.78 Million | $119.57 Million | — |